Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
DOI:
https://doi.org/10.26641/2307-0404.2019.4.189182Keywords:
neobladder, pharmacological correction, experimental in vivo, new chemical compoundsAbstract
The aim of this work was to study the possibility of pharmacological correction of the neobladder contractile activity of mini-pigs under the influence of new chemical compounds, m-anticholinergic (solifenacin), selective beta-2 sympathomimetic (ginipral (hexoprenaline)) in vivo. Neobladder, formed from the distal section of ileum, pre-denervated along the anti-mesenteric margin, retains peristalsis, and given the sharp thickening of the muscle layer, capable to contractile reactions and tone support. New chemical compounds pyrrole-2-carbaldehyde 2- hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated spasmodic properties directed at smooth muscle in vivo. Compound PChBh (I) showed more pronounced relaxing properties compared to compound IBh (II), reducing basal pressure against KCl by 40.91%, contraction amplitude by 30.63%, contraction rate by 25.49%. Solifenacin, being an m-anticholinergic antagonist, most clearly demonstrated antispasmodic properties in vivo, reducing hypertonicity by 55.23%, amplitude – by 49.31%, frequency of contractions in 10 minutes – by 57.40%, duration of contractions – by 18.18%. Selective beta-2-sympathomimetic hexoprenaline, previously used to relieve hypertonicity of a pregnant uterus actively affects intestinal motility. Hexoprenaline inhibited bladder overactivity with KCl, decreasing basal pressure by 58.75%, the amplitude of the contractions – by 39.62%, frequency rate – by 57.49%, reductions in the duration – by 54.55%. Preparations from the group of m-anticholinergics and selective beta-2-sympathomimetics showed a pronounced antispasmodic effect in experiment in vivo and can be used to correct incontinence in patients after orthotopic bladder repair. The new chemical compounds pyrrole-2-carbaldehyde 2-hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated antispasmodic properties in the experiment in vitro, and confirmed an antispasmodic effect in the experiment in vivo, promising further research, determining safety and efficacy.
References
Moskalenko VF, GulchIy OP, Golubchikov MV. [Biostatistika]. Kyiv: Knigaplyus. 2009;184. Ukrainian.
Savchuk RV, Zhukovsky DO, Kostev FI. [Method for modeling artifical bladder in experiment on female pigs Utility model patent No 122281, U, Ukraine, IPC A61B 17/00. / N u2017 08162; 07.08.2017; Publ. 26.12.2017. Bull. No. 24] 2017. Ukrainian.
Chang DT, Lawrentschuk N. Orthotopic neobladder reconstruction. Urol Ann. 2015;7(1):1-7. doi: https://doi.org/10.4103/0974-7796.148553
Fumitaka Koga, Kazunori Kihara. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: A contemporary review. Int J Urol. 2012 May;19(5):388-401. doi: https://doi.org/10.1111/j.1442-2042.2012.02974.x
Schafer W, Abrams P, Liao L, et al. Good urodynamic practice: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol. Urodyn. 2002;21:261-74. doi: https://doi.org/10.1002/nau.10066
Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan;63(1):45-57. Epub 2012 Aug 14. doi: https://doi.org/10.1016/j.eururo.2012.08.009
Nathan Hoag, Vincent Tse, Audrey Wang, Eric Chung, and Johan Gani. Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy. Int Neurourol J. 2016 Mar;20(1):81-85. Published online 2016 Mar 7. doi: https://doi.org/10.5213/inj.1630380.190
Leonardo L. Monteiro and Wassim Kassouf. Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes. Int Braz J Urol. 2017 Mar-Apr;43(2):184-7. doi: https://doi.org/10.1590/s1677-5538.ibju.2017.02.03
Antonio Luigi Pastore, Giovanni Palleschi, Luigi Silvestri, Giuseppe Cavallaro, Mario Rizzello, Gianfranco Silecchia, et al. Pure intracorporeal laparoscopic radical cystectomy with orthotopic "U" shaped ileal neobladder. BMC Urol. 2014;14:89. Published online 2014 Nov 18. doi: https://doi.org/10.1186/1471-2490-14-89
Santucci RA, Park CH, Mayo ME, Lange PH. Continence and urodynamic parameters of continent urinary reservoirs: comparison of gastric, ileal, ileocolic, right colon, and sigmoid segments. Urology. 1999;54:252-7. doi: https://doi.org/10.1016/S0090-4295(99)00098-9.
Savchuk RV, Zhukovsky DA, Shmatkova NV. Regulation of the Contractile Activity of the Small Intestine Isolated Segment in Vitro. Int J Pharm and Chemistry. 2017;3(5):62-6. doi: https://doi.org/10.11648/j.ijpc.20170305.11
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. Epub 2012 Jan;4. doi: https://doi.org/10.3322/caac.20138
Singh V, Yadav R, Sinha R, Gupta D. Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. BJU Int. 2014 May;113(5):726-32. doi: https://doi.org/10.1111/bju.12440
Cerruto MA, D'Elia C, Siracusano S, Gedeshi X, Mariotto A, Niero M, et al. Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. Eur J Surg Oncol. 2016 Mar;42(3):343-60. Epub 2015 Nov 9. doi: https://doi.org/10.1016/j.ejso.2015.10.001
Ameeta L Nayak, Ilias Cagiannos, Luke T Lavallée, Chris Morash, Duane Hickling, Ranjeeta Mallick, et al. Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction. Can Urol Assoc J. 2018 Jun;12(6):181-6. Published online 2018 Feb 23. doi: https://doi.org/10.5489/cuaj.4877
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2019 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
